Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.
作者信息
Testa R, Grasso A, Dagnino F, Ibba R, Varagona G, Celle G
出版信息
Br J Clin Pharmacol. 1987 Jun;23(6):779-80.
Abstract
摘要
相似文献
1
Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.
Br J Clin Pharmacol. 1987 Jun;23(6):779-80.
2
Effect of famotidine on hepatic hemodynamics and peptic ulcer.
Am J Gastroenterol. 1987 May;82(5):415-8.
3
A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
Br J Clin Pharmacol. 1989 Jan;27(1):83-7. doi: 10.1111/j.1365-2125.1989.tb05338.x.
4
Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
Clin Ther. 1987;9(5):528-35.
5
[Negative inotropic action of famotidine].
Schweiz Med Wochenschr. 1988 Dec 17;118(50):1912-4.
6
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].
Arzneimittelforschung. 1984;34(9):1041-2.
7
Effect of famotidine on theophylline clearance in asthma and COPD patients.
Arerugi. 1987 Nov;36(11):1012-7.
8
[Effects of famotidine on plasma pentazocine concentration in surgical patients].
Masui. 1988 Jun;37(6):701-6.
9
[Action of famotidine, a new H2-receptor antagonist, on the papillary muscle and atrium of the guinea pig, in vitro].
Cardiologia. 1987 Sep;32(9):1025-9.
10
Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide.
Anticancer Res. 1988 Nov-Dec;8(6):1241-5.
引用本文的文献
1
Whole-Blood Taurine Concentrations in Cats With Intestinal Disease.
J Vet Intern Med. 2017 Jul;31(4):1067-1073. doi: 10.1111/jvim.14773. Epub 2017 Jun 19.
2
Haematological adverse effects of histamine H2-receptor antagonists.
Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):430-48. doi: 10.1007/BF03259895.
3
Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.
Clin Pharmacokinet. 1988 Oct;15(4):205-15. doi: 10.2165/00003088-198815040-00001.
4
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
Drugs. 1989 Oct;38(4):551-90. doi: 10.2165/00003495-198938040-00005.
5
A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
Br J Clin Pharmacol. 1989 Jan;27(1):83-7. doi: 10.1111/j.1365-2125.1989.tb05338.x.
6
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
7
Clinical pharmacokinetics of famotidine.
Clin Pharmacokinet. 1991 Sep;21(3):178-94. doi: 10.2165/00003088-199121030-00003.
本文引用的文献
1
SPECTROPHOTOMETRIC DETERMINATION OF INDOCYANINE GREEN IN PLASMA ESPECIALLY WITH A VIEW TO AN IMPROVED CORRECTION FOR BLANK DENSITY.
Scand J Clin Lab Invest. 1963;15:613-21. doi: 10.3109/00365516309051344.
2
Half-life time or clearance of indocyanine green in patients with liver disease.
Hepatogastroenterology. 1982 Apr;29(2):55-7.
3
Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
Clin Sci (Lond). 1983 Feb;64(2):207-12. doi: 10.1042/cs0640207.
4
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid.
Eur J Clin Invest. 1980 Aug;10(4):261-71. doi: 10.1111/j.1365-2362.1980.tb00032.x.
5
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.
Br J Clin Pharmacol. 1984 Jul;18(1):105-6. doi: 10.1111/j.1365-2125.1984.tb05031.x.
6
Serum bile acid determination after different doses of orally ingested chenodeoxycholic acid. Evaluation of a simplified enzymatic method.
Scand J Gastroenterol. 1985 Dec;20(10):1221-6. doi: 10.3109/00365528509089280.
7
Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function.
J Hepatol. 1985;1(6):609-17. doi: 10.1016/s0168-8278(85)80004-0.
8
Effect of famotidine on oxidative drug metabolism.
Eur J Clin Pharmacol. 1986;30(3):279-81. doi: 10.1007/BF00541528.
9
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.
Eur J Clin Pharmacol. 1985;28(6):671-5. doi: 10.1007/BF00607913.
Zotero 插件